Therapy for HER2-Positive Metastatic Breast Cancer

N Engl J Med. 2020 Jun 18;382(25):e98. doi: 10.1056/NEJMc2004854.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms*
  • Capecitabine
  • Humans
  • Receptor, ErbB-2
  • Trastuzumab

Substances

  • Capecitabine
  • Receptor, ErbB-2
  • Trastuzumab